** Evotec's EVTG.DE shares drop around 16% in volume spike after biotech company Halozyme HALO.O said it withdrew its offer to acquire the German drug development company
** If losses hold Evotec's shares will see their worst day since July; about 1.5 million shares changed hands so far today, around 63% of their 30-day moving average full-day volume
** The stock falls to the bottom of Germany's small-cap index .SDAXI
(Reporting by Tristan Veyet)
((Tristan.chabba@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。